-----------------------------------------
CONTRIBUTOR DISCLOSURES AND AFFILIATIONS
-----------------------------------------

-- TITLE 1 --------------------- 
Co-Moderator

-- NAME 1 --------------------- 
Kenneth A. Alexander, MD, PhD

-- AFFILIATION 1 --------------------- 
Chief
<br/>
Division of Infectious Diseases
<br/>
Nemours Children's Hospital
<br/>
Orlando, Florida

-- DISCLOSURE 1 --------------------- 
Disclosure: Kenneth A. Alexander, MD, PhD, has disclosed the following relevant financial relationships: 

<br/> Served as an advisor or consultant for: Merck &amp; Co., Inc.; Merck Sharp &amp; Dohme Corp.

<br/> Served as a speaker or a member of a speakers bureau for: Merck &amp; Co., Inc.; Merck Sharp &amp; Dohme Corp. 

<br/><br/>Dr Alexander does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

<br/><br/>Dr Alexander does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.


-- TITLE 2 --------------------- 
Co-Moderator

-- NAME 2 --------------------- 
Suzanne M. Garland, AO, MBBS, MD, FRCPA, FRANZCOG&#160;<em>Ad Eundem,&#160;</em>FAChSHM, FASM, FFSc(RCPA)

-- AFFILIATION 2 --------------------- 
Professor
<br/>
Reproductive &amp; Neonatal Infectious Diseases
<br/>
Department of Obstetrics and Gynecology
<br/>
Melbourne Medical School
<br/>
Melbourne, Australia

-- DISCLOSURE 2 --------------------- 
Disclosure: Suzanne M. Garland, MD, has disclosed the following relevant financial relationships: 

<br/> Served as a speaker or a member of a speakers bureau for: Merck Sharp &amp; Dohme Corp. 

<br/> Received grants for clinical research from: Merck Sharp &amp; Dohme Corp. 

<br/><br/>Dr Garland does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

<br/><br/>Dr Garland does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

-- TITLE 3 --------------------- 
Panelists

-- NAME 3 --------------------- 
Suresh Kumarasamy, MBBS, MObGyn, FRCOG, FRCPI

-- AFFILIATION 3 --------------------- 
Adjunct Clinical Professor
<br/>
Penang Medical College
<br/>
Consultant Gynecologist and Gynecological Oncologist
<br/>
Gleneagles Penang
<br/>
Georgetown, Malaysia

-- DISCLOSURE 3 --------------------- 
Disclosure: Suresh Kumarasamy, MBBS, MObGyn, FRCOG, FRCPI, has disclosed the following relevant financial relationships: 

<br/> Served as an advisor or consultant for: AstraZeneca Pharmaceuticals LP; Bayer HealthCare; Merck &amp; Co., Inc. 

<br/> Served as a speaker or a member of a speakers bureau for: AstraZeneca Pharmaceuticals LP; Bayer HealthCare; Merck &amp; Co., Inc. 

<br/><br/>Dr Kumarasamy does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

<br/><br/>Dr Kumarasamy does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.


-- TITLE 4 --------------------- 
Panelists

-- NAME 4 --------------------- 
Batmunkh Tsetsegsaikhan, PhD, MPH/MHM

-- AFFILIATION 4 --------------------- 
Founder &amp; CEO
<br/>
National Cancer Council of Mongolia
<br/>
Ulaanbaatar, Mongolia

-- DISCLOSURE 4 --------------------- 
Disclosure: Batmunkh Tsetsegsaikhan, PhD, MPH/MHM, has disclosed no relevant financial relationships. 

<br/><br/>Dr Tsetsegsaikhan does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

<br/><br/>Dr Tsetsegsaikhan does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.
